MELINA BREWER: Open Payments
NPI 1275170474 · ANNVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 60 payments from 9 companies in 2025. Trend: 2023 $785 · 2024 $1,076 · 2025 $926
Food & beverage: $926
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $298 |
| Novo Nordisk Inc | 10 | $199 |
| Lilly USA, LLC | 9 | $184 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| IBSA Pharma Inc. | 3 | $60 |
| GlaxoSmithKline, LLC. | 2 | $55 |
| Exact Sciences Corporation | 1 | $24 |
| Amgen Inc. | 1 | $17 |
| Acella Pharmaceuticals, LLC | 1 | $16 |
Products named: Wegovy, VRAYLAR, MOUNJARO, UBRELVY, QULIPTA, Tirosint, SHINGRIX, KISUNLA.
Industry payments across PA — which companies pay providers there.
